CLINICAL TRIALS PROFILE FOR TIMENTIN IN PLASTIC CONTAINER
✉ Email this page to a colleague
All Clinical Trials for TIMENTIN IN PLASTIC CONTAINER
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02158442 ↗ | Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients | Completed | Osprey Medical, Inc | Phase 2 | 2013-10-01 | The use of the Percutaneous Isolated Limb Procedure (PILP) which enables the use of existing antibiotic therapies in a more targeted and concentrated fashion in patients with diabetes who have a significant lower limb infection and it is deemed that IV antibiotics are needed in order to salvage the limb or life. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TIMENTIN IN PLASTIC CONTAINER
Condition Name
Clinical Trial Locations for TIMENTIN IN PLASTIC CONTAINER
Clinical Trial Progress for TIMENTIN IN PLASTIC CONTAINER
Clinical Trial Phase
Clinical Trial Sponsors for TIMENTIN IN PLASTIC CONTAINER
Sponsor Name